STOCK TITAN

Definitive Healthcare Corp. - DH STOCK NEWS

Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.

Company Overview

Definitive Healthcare Corp (DH) is a renowned provider of healthcare commercial intelligence and an expert in leveraging a robust SaaS platform to transform complex healthcare data into actionable insights. As a subscription-based service, it aggregates and refines vast amounts of information from a diverse array of healthcare providers including hospitals, physicians, ambulatory surgery centers, imaging centers, long-term care facilities, and more. Using advanced data science and analytics, the company delivers a comprehensive view of the healthcare ecosystem in the United States, empowering clients to develop data-driven strategies, segment markets accurately, and optimize commercial operations with confidence.

Business Model and Revenue Generation

The company’s business model is anchored in the provision of a versatile, subscription-driven platform that delivers uninterrupted access to high-quality, curated data. Rather than relying on periodic sales cycles or one-off engagements, Definitive Healthcare focuses on maintaining continuous customer relationships through its SaaS-based service offerings. Clients—all of whom are stakeholders in healthcare, from provider networks and pharmaceutical companies to medtech organizations and insurance companies—benefit from regular updates, quality-assured data, and seamless integration into their operational workflows. Revenue is generated mainly through recurring subscriptions and tailored support services, which reflects the company’s commitment to delivering ongoing value to its customers.

Key Solutions and Product Offerings

Definitive Healthcare has developed an extensive array of solutions designed to address the multi-dimensional needs of its users. Its product suite emphasizes:

  • Comprehensive Data Aggregation: The platform curates data on thousands of healthcare facilities and professionals, facilitating market segmentation, competitive analysis, and strategic planning.
  • Advanced Analytics and Data Science: Through the use of deep analytics, clients are provided with granular insights that help identify critical market trends and refined customer segments, essential for tailored go-to-market strategies.
  • Mobile and On-Demand Intelligence: The DH View Suite mobile app ensures that crucial intelligence is accessible anywhere at any time, allowing sales and marketing teams to be prepared in real time.
  • Predictive and Scenario Analysis: Tools such as Market Forecast enable organizations to visualize market trends and demand projections, equipping decision-makers with a forward-looking view of service line opportunities while remaining grounded in historical data and proven analytic models.
  • Integrated Engagement Solutions: Through products like Monocl Conferences and Population Intelligence, the company facilitates seamless connection and collaboration among pharmaceutical companies, KOLs, and life science organizations, streamlining conference planning and audience targeting processes.

Data and Analytics Excellence

At the core of Definitive Healthcare’s offering is its commitment to accurate, comprehensive, and continuously updated data. The platform employs advanced methodologies to ensure that the information provided is not only extensive but also contextually enriched. Clients benefit from detailed profiles that extend beyond mere lists of providers to include insights into clinical performance, financial health, quality metrics, and the adoption of installed technologies. This meticulous approach to data quality ensures that healthcare professionals and corporate teams have both the breadth and depth of information required for thorough market research and intelligent strategic planning.

Market Position and Competitive Advantage

Within the crowded field of healthcare data providers, Definitive Healthcare distinguishes itself through its scale, the granularity of its data, and its ability to integrate diverse analytics into a holistic intelligence platform. The company serves multiple market segments, effectively bridging the gap between data generation and actionable intelligence. This approach not only supports traditional market research but also allows clinical and commercial teams to uncover new market opportunities, tailor their engagement strategies, and refine customer segmentation with exceptional precision. The combination of customizable tools and real-time access to data is a significant differentiator in an industry where time-sensitive insights can be the key to unlocking commercial success.

Client Impact and Applications

Definitive Healthcare’s impact is realized across various facets of the healthcare industry. For sales and marketing teams, the mobile-first solutions provide a tactical edge enabling pre-meeting preparation and post-engagement follow-up. Strategic planners and market analysts utilize advanced predictive tools like Market Forecast to identify emerging trends and allocate resources efficiently. Moreover, the integration of comprehensive data with intuitive platforms empowers organizations to recalibrate their go-to-market strategies, optimize operational performance, and achieve cost efficiencies without sacrificing the quality of engagement. The platform’s design is inherently flexible, catering to the unique requirements of diverse client types—from academic medical centers to global pharmaceutical corporations—thus ensuring that every customer derives maximum value from their investment in data-driven insights.

Expertise, Experience, and Industry Authority

Definitive Healthcare embodies the principles of Expertise, Experience, Authoritativeness, and Trustworthiness (E-E-A-T) in every facet of its operations. The company employs industry veterans and data scientists who specialize in healthcare analytics, ensuring that the intelligence provided is rooted in practical experience and rigorous analysis. Its commitment to accuracy and depth is reflected in every aspect of its data curation process, with an unwavering focus on eliminating inaccuracies and delivering value through meticulous data management. This disciplined approach to quality control not only elevates the standard of commercial intelligence in the healthcare arena but also instills trust among its clients, who rely on the platform for critical decision-making and strategic direction. Additionally, the company’s open engagement with its marketplace through educational webinars, conference presentations, and thought leadership articles further underscores its standing as a bidder of expert insight in the dynamic healthcare landscape.

Operational Excellence and Integration

Operationally, the company is designed for adaptability and precision. Its cloud-based infrastructure allows for seamless updates and integration with internal systems, ensuring that organizations do not encounter disruptions in their workflows. Whether accessed via desktop or mobile devices, the platform’s intuitive interface facilitates a smooth user experience. This operational excellence has made it a critical tool for organizations that need to remain agile in response to rapid changes in market conditions and technological advances. With an emphasis on continuous improvement and innovation, Definitive Healthcare frequently enhances its product offerings, incorporating refined analytics, enhanced user interface features, and expanded data points that collectively offer a potent mix of depth, detail, and usability.

Industry Insights and Continuous Learning

The company’s overarching mission is to transform fragmented data sources into a cohesive intelligence framework that supports the dynamic needs of modern healthcare professionals. Its expansive database serves as both a repository of historical trends and a catalyst for future innovation, enabling clients to stay ahead by basing strategies on robust, integrative intelligence. By powering strategic conversations around healthcare trends, patient demographics, and market dynamics, Definitive Healthcare is not only addressing current challenges but also enabling its clients to anticipate future developments with a well-informed perspective. The platform’s capacity to integrate real-time data with predictive analytics creates a compelling value proposition for stakeholders looking to fortify their competitive positioning in a constantly evolving healthcare landscape.

Conclusion

In summary, Definitive Healthcare Corp stands out as a key provider of healthcare commercial intelligence, renowned for its comprehensive data platform, advanced analytical tools, and commitment to delivering precise, actionable insights. Through its diverse suite of products and an unwavering focus on operational excellence and data quality, the company facilitates informed strategic decision-making and robust market intelligence across the healthcare industry. Whether for identifying new market opportunities, optimizing sales strategies, or refining operational approaches, the platform’s capacity to integrate data, analytics, and real-world expertise underscores its essential role in navigating the complexities of today’s healthcare market.

Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH) will report its Q4 and full year 2021 financial results on February 23, 2022, post-market close. The company will also host a conference call and webcast at 5:00 PM ET to discuss these results. Investors can access the live audio webcast via the Investor Relations website. A replay of the call will be available shortly after its conclusion and will remain accessible until March 9, 2022. Definitive Healthcare specializes in healthcare commercial intelligence, leveraging data and analytics for market success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.53%
Tags
-
Rhea-AI Summary

Definitive Healthcare (Nasdaq: DH) launched Latitude Discovery on January 25, 2022, aimed at aiding pre-commercial biopharma and medical device companies. This innovative tool allows users to perform iterative analyses of real-world data to evaluate market opportunities linked to therapy development. Latitude Discovery provides self-service access to extensive market intelligence, enabling efficient cohort creation and real-time commercial intelligence visualizations. This product is part of the Latitude Analytics Suite, enhancing companies' commercialization efforts with precise analytics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.43%
Tags
none
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) has announced its inclusion in the Russell 1000® Index, effective from December 20, 2021. This milestone aims to enhance the company's visibility to investors and broaden its shareholder base. CEO Jason Krantz expressed optimism about this change, stating it enables the introduction of healthcare commercial intelligence to a wider audience, helping businesses succeed in the complex healthcare market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
none
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) announced that CEO Jason Krantz and CFO Rick Booth will present at the Barclays Virtual Global Technology, Media and Telecommunications Conference on December 7, 2021, at 9:45 a.m. Eastern Time. The live presentation will be accessible via the investor relations page of Definitive Healthcare's website, with a limited-time replay available afterward. Definitive Healthcare specializes in healthcare commercial intelligence, providing a SaaS platform to help clients identify market opportunities and drive commercial success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.25%
Tags
conferences
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) has successfully closed its underwritten public offering of 11 million shares of Class A common stock at $36.00 per share. Underwriters hold a 30-day option for an additional 1.65 million shares. Proceeds will fund acquisitions and general corporate purposes, including buying 7 million limited liability interests from AIDH TopCo, LLC, and repurchasing 2.23 million shares of its Class A stock. Goldman Sachs and J.P. Morgan led the offering with support from Morgan Stanley and Barclays.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.34%
Tags
none
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) announced a public offering of 11 million shares of its Class A common stock at $36.00 per share. The offering includes a 30-day option for underwriters to purchase an additional 1.65 million shares. Closing is anticipated on November 22, 2021. Proceeds will fund acquisitions and general corporate purposes, such as buying 7 million limited liability interests from its subsidiary and repurchasing 2.23 million Class A shares. The offering is managed by Goldman Sachs & Co. and J.P. Morgan among others.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.51%
Tags
none
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) has initiated a public offering of 11,000,000 shares of its Class A common stock, with an option for underwriters to acquire an additional 1,650,000 shares. The net proceeds will fund acquisitions and general corporate purposes, including purchasing up to 7,000,000 limited liability interests from its subsidiary, AIDH TopCo, LLC, and repurchasing up to 2,233,238 shares of Class A stock. The offering is managed by leading financial firms, with a prospectus available through the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.88%
Tags
none
-
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) reported a strong Q3 2021, with revenue of $43.1 million, up 43% year-over-year. However, the company incurred a GAAP net loss of $(21.0) million, a significant rise from $(10.0) million in Q3 2020. Adjusted net income fell to $2.2 million compared to $5.1 million in the same quarter last year. The company forecasted Q4 2021 revenue between $44 million and $45 million, expecting a 32% year-over-year increase. Despite the losses, customer growth surged by 49%, reaching 377 clients with $100,000 or greater in annual recurring revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.69%
Tags
-
Rhea-AI Summary

Definitive Healthcare has integrated extensive Asian data sources into Monocl ExpertInsight, enhancing its platform with over 11 million worldwide expert profiles, focusing on the Chinese and Japanese healthcare markets. This expansion responds to customer demand for deeper insights in the APAC region, facilitating better expert identification and engagement strategies. The update includes local language capabilities, aiding medical professionals in understanding local experiences and exploring new scientific activities. This move aims to strengthen relationships and expand market presence in Asia-Pacific.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
none
Rhea-AI Summary

Definitive Healthcare Corp. (Nasdaq: DH) will release its third quarter financial results on November 8, 2021, after market close. A conference call is scheduled for 5:00 PM ET to discuss the results. Investors can access a live audio webcast on Definitive Healthcare’s Investor Relations website and dial in via provided numbers. The call will also be available for replay until November 22, 2021. Definitive Healthcare focuses on providing data and analytics to enhance commercial success in the healthcare sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.88%
Tags

FAQ

What is the current stock price of Definitive Healthcare (DH)?

The current stock price of Definitive Healthcare (DH) is $2.5 as of April 15, 2025.

What is the market cap of Definitive Healthcare (DH)?

The market cap of Definitive Healthcare (DH) is approximately 286.8M.

What is Definitive Healthcare Corp?

Definitive Healthcare Corp (DH) provides a SaaS-based platform delivering comprehensive, high-quality data and analytics on the healthcare ecosystem to support informed decision-making.

How does Definitive Healthcare generate revenue?

The company primarily generates revenue through subscription fees for access to its commercial intelligence platform, which includes continuous support and periodic updates.

What types of healthcare providers are included in its data?

The platform aggregates data on various healthcare providers, including hospitals, physicians, ambulatory surgery centers, imaging centers, long-term care facilities, and more.

How does the DH platform aid in strategic planning?

It delivers detailed analytics, predictive modeling, and market segmentation tools that enable clients to identify new market opportunities and refine their go-to-market strategies.

What are some of the key product offerings of Definitive Healthcare?

Key offerings include the core commercial intelligence platform, mobile solutions like DH View Suite, predictive tools such as Market Forecast, and integrated engagement solutions through products like Monocl Conferences.

Who are the typical clients of Definitive Healthcare?

The platform serves a broad range of clients including healthcare providers, pharmaceutical companies, medtech organizations, and other stakeholders requiring detailed market and operational insights.

How is data quality maintained on the platform?

Definitive Healthcare uses advanced analytics and rigorous data curation methodologies to ensure accuracy, comprehensiveness, and contextual relevance across its extensive database.

How does Definitive Healthcare differentiate itself from competitors?

Through its expansive data coverage, advanced analytics, mobile accessibility, and integrated suite of tools, the company offers a robust, dynamic intelligence platform that stands apart in the healthcare sector.
Definitive Healthcare Corp.

Nasdaq:DH

DH Rankings

DH Stock Data

286.79M
40.31M
7.14%
94.68%
2.46%
Health Information Services
Services-prepackaged Software
Link
United States
FRAMINGHAM